Cetuximab May Prolong Survival For Head And Neck Cancer Patients
Fri, 19 Jan 2007 08:00 AM EST
... Preliminary findings show adding the chemotherapy drug cetuximab (brand name Erbitux) to radiation therapy and chemotherapy may help some patients with head and neck cancer live longer, according to a study presented today at the plenary session of the Multidisciplinary Head and Neck Cancer [click link for full article] ...

Not Signed In -


